Literature DB >> 18339838

Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle.

Anik L Côté1, Edward J Usherwood, Mary Jo Turk.   

Abstract

Antitumor immune responses can be stimulated by interfering with regulatory T-cell (T(reg)) function. However, this effect is short lived unless T-cell memory to tumor antigens can be generated. Our recent studies show that T(reg) cells not only limit primary responses to tumor/self-antigens in tumor-bearing hosts but also prevent the natural generation of T-cell memory to such antigens. Here, we discuss the role of T(reg) cells in suppressing T-cell memory after surgical excision of tumors and the potential clinical benefits of overcoming this suppression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339838      PMCID: PMC2682528          DOI: 10.1158/0008-5472.CAN-07-6012

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  CD25+CD4+ T cells contribute to the control of memory CD8+ T cells.

Authors:  Masaaki Murakami; Akemi Sakamoto; Jeremy Bender; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

2.  Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation.

Authors:  Robbert G van der Most; Kaja Murali-Krishna; J Gibson Lanier; E John Wherry; Maryann T Puglielli; Joseph N Blattman; Alessandro Sette; Rafi Ahmed
Journal:  Virology       Date:  2003-10-10       Impact factor: 3.616

Review 3.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Immunological consequences of tumor excision: from active immunity to immunological memory.

Authors:  I Bursuker; R J North
Journal:  Int J Cancer       Date:  1986-02-15       Impact factor: 7.396

5.  Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.

Authors:  A van Elsas; A A Hurwitz; J P Allison
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

6.  Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor.

Authors:  Peisheng Zhang; Anik L Côté; Victor C de Vries; Edward J Usherwood; Mary Jo Turk
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

7.  Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections.

Authors:  Michael J Fuller; Aaruni Khanolkar; Anne E Tebo; Allan J Zajac
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

Review 8.  Central memory and effector memory T cell subsets: function, generation, and maintenance.

Authors:  Federica Sallusto; Jens Geginat; Antonio Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

9.  Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.

Authors:  Mary Jo Turk; José A Guevara-Patiño; Gabrielle A Rizzuto; Manuel E Engelhorn; Shimon Sakaguchi; Alan N Houghton
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

Authors:  David W Mullins; Stacey L Sheasley; Rebecca M Ream; Timothy N J Bullock; Yang-Xin Fu; Victor H Engelhard
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307

View more
  11 in total

1.  Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.

Authors:  Jarrod D Predina; Brendan Judy; Veena Kapoor; Aaron Blouin; Louis A Aliperti; Daniel Levine; Olugbenga T Okusanya; Jon Quatromoni; Zvi G Fridlender; Sunil Singhal
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

2.  Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).

Authors:  Baldev Vasir; Corrine Zarwan; Rehan Ahmad; Keith D Crawford; Hassan Rajabi; Ken-Ichi Matsuoka; Jacalyn Rosenblatt; Zekui Wu; Heidi Mills; Donald Kufe; David Avigan
Journal:  J Immunother       Date:  2012-09       Impact factor: 4.456

3.  Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.

Authors:  Kimberly R Jordan; Rodabe N Amaria; Oscar Ramirez; Eryn B Callihan; Dexiang Gao; Michelle Borakove; Elizabeth Manthey; Virginia F Borges; Martin D McCarter
Journal:  Cancer Immunol Immunother       Date:  2013-09-27       Impact factor: 6.968

Review 4.  Immunomodulatory cytokines as therapeutic agents for melanoma.

Authors:  Courtney Nicholas; Gregory B Lesinski
Journal:  Immunotherapy       Date:  2011-05       Impact factor: 4.196

5.  Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells.

Authors:  Drew J Roberts; Nathan A Franklin; Lara M Kingeter; Hideo Yagita; Alison L Tutt; Martin J Glennie; Timothy N J Bullock
Journal:  J Immunother       Date:  2010-10       Impact factor: 4.456

6.  Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.

Authors:  Katelyn T Byrne; Anik L Côté; Peisheng Zhang; Shannon M Steinberg; Yanxia Guo; Rameeza Allie; Weijun Zhang; Marc S Ernstoff; Edward J Usherwood; Mary Jo Turk
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

7.  Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.

Authors:  Margaret Gil; Magdalena Bieniasz; Andrzej Wierzbicki; Barbara J Bambach; Hanna Rokita; Danuta Kozbor
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

8.  Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection.

Authors:  Erik L Brincks; Alan D Roberts; Tres Cookenham; Stewart Sell; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  J Immunol       Date:  2013-03-06       Impact factor: 5.422

9.  Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell help.

Authors:  Anik L Côté; Katelyn T Byrne; Shannon M Steinberg; Peisheng Zhang; Mary Jo Turk
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

10.  Forced co-expression of IL-21 and IL-7 in whole-cell cancer vaccines promotes antitumor immunity.

Authors:  Yang-Zhuo Gu; Chuan-Wen Fan; Ran Lu; Bin Shao; Ya-Xiong Sang; Qiao-Rong Huang; Xue Li; Wen-Tong Meng; Xian-Ming Mo; Yu-Quan Wei
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.